Filter

Refine by collections

Refine by date

—
  • Print
  • Save

Search Results

You are looking at 1 - 10 of 60 items for :

  • prednisolone x
Clear All
Angelica Sharma Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Angelica Sharma in
Google Scholar
PubMed Close
,
Katharine Lazarus Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Katharine Lazarus in
Google Scholar
PubMed Close
,
Deborah Papadopoulou Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Deborah Papadopoulou in
Google Scholar
PubMed Close
,
Hemanth Prabhudev Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed Close
,
Tricia Tan Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK

Search for other papers by Tricia Tan in
Google Scholar
PubMed Close
,
Karim Meeran Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed Close
, and
Sirazum Choudhury Division of Diabetes, Endocrinology and Metabolism, Department of Metabolism, Digestion and Reproduction, Imperial College London, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, North West London Pathology, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed Close

) prednisolone ( 4 ). Over-replacement with glucocorticoids avoids adrenal crisis at the expense of an increased risk of developing multiple comorbidities, including obesity, diabetes, cardiovascular disease, and osteoporosis ( 5 ). It is crucial to achieve an

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-23-0097
Volume/Issue:
Volume 12: Issue 8
Open access
David J F Smith Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by David J F Smith in
Google Scholar
PubMed Close
,
Hemanth Prabhudev Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Hemanth Prabhudev in
Google Scholar
PubMed Close
,
Sirazum Choudhury Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Clinical Biochemistry, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed Close
, and
Karim Meeran Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK
Department of Investigative Medicine, Division of Diabetes, Endocrinology and Metabolism, Imperial College London, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed Close

mineralocorticoid production in primary adrenal failure. The mainstay of treatment is glucocorticoid replacement, with either hydrocortisone or prednisolone ( 2 ). Both work by binding to the glucocorticoid receptor (GR) for which prednisolone has the greater

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-17-0257
Volume/Issue:
Volume 6: Issue 8
Open access
Pernille H Hellmann Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed Close
,
Jonatan I Bagger Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed Close
,
Katrine R Carlander Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark

Search for other papers by Katrine R Carlander in
Google Scholar
PubMed Close
,
Katrine B Hansen Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Katrine B Hansen in
Google Scholar
PubMed Close
,
Julie L Forman Section of Biostatistics, Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Julie L Forman in
Google Scholar
PubMed Close
,
Joachim Størling Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Joachim Størling in
Google Scholar
PubMed Close
,
Elizaveta Chabanova Department of Radiology, Herlev Hospital, University of Copenhagen, Herlev, Denmark

Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed Close
,
Jens Holst Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Jens Holst in
Google Scholar
PubMed Close
,
Tina Vilsbøll Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark

Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed Close
, and
Filip K Knop Center for Clinical Metabolic Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Filip K Knop in
Google Scholar
PubMed Close

Introduction Prednisolone, a corticosteroid-based drug, is used in a wide range of diseases due to its anti-inflammatory and immunosuppressant effects ( 1 , 2 , 3 , 4 ). Glucocorticoids affect various human tissues, and it has been shown

Article Type:
Research Article
Collections:
Metabolic Syndrome and Diabetes
DOI:
https://doi.org/10.1530/EC-22-0334
Volume/Issue:
Volume 12: Issue 4
Open access
Kathrin R Frey Department of Medicine I, Endocrine and Diabetes Unit, University Hospital, University of Würzburg, Würzburg, Germany

Search for other papers by Kathrin R Frey in
Google Scholar
PubMed Close
,
Tina Kienitz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Tina Kienitz in
Google Scholar
PubMed Close
,
Julia Schulz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Julia Schulz in
Google Scholar
PubMed Close
,
Manfred Ventz Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Manfred Ventz in
Google Scholar
PubMed Close
,
Kathrin Zopf Charité – Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany

Search for other papers by Kathrin Zopf in
Google Scholar
PubMed Close
, and
Marcus Quinkler Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Marcus Quinkler in
Google Scholar
PubMed Close

dose resulted in an increase in lumbar spine and total hip BMD in a large cohort of PAI and CAH ( 28 ). However, no longitudinal study has examined the effect of different GCs in detail. Prednisolone is used in approx. 5% of patients with AI as

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0160
Volume/Issue:
Volume 7: Issue 6
Open access
Dafydd Aled Rees Cardiff University, Cardiff, United Kingdom

Search for other papers by Dafydd Aled Rees in
Google Scholar
PubMed Close
,
Deborah P Merke National Institutes of Health Clinical Center and the Eunice Kennedy Shriver National Institute of Child Health and Human Development, Bethesda, USA

Search for other papers by Deborah P Merke in
Google Scholar
PubMed Close
,
Wiebke Arlt MRC LMS, London, United Kingdom

Search for other papers by Wiebke Arlt in
Google Scholar
PubMed Close
,
Aude Brac De La Perriere Hospices Civils de Lyon - GHE - Endocrinologie, Bron, France

Search for other papers by Aude Brac De La Perriere in
Google Scholar
PubMed Close
,
Angelica Linden Hirschberg Karolinska Institute, Solna, Sweden

Search for other papers by Angelica Linden Hirschberg in
Google Scholar
PubMed Close
,
Anders Juul Department of Growth and Reproduction, Copenhagen University Hospital - Rigshospitalet, Copenhagen, Denmark, and Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark

Search for other papers by Anders Juul in
Google Scholar
PubMed Close
,
John Newell-Price The University of Sheffield, Sheffield, United Kingdom

Search for other papers by John Newell-Price in
Google Scholar
PubMed Close
,
Alessandro Prete University of Birmingham, Birmingham, United Kingdom

Search for other papers by Alessandro Prete in
Google Scholar
PubMed Close
,
Nicole Reisch Endokrinologie, Nephrologie und weitere Sektionen - Medizinische Klinik und Poliklinik IV - Campus Innenstadt, München, Germany

Search for other papers by Nicole Reisch in
Google Scholar
PubMed Close
,
Nike M Stikkelbroeck Radboud University Nijmegen, Nijmegen, Netherlands

Search for other papers by Nike M Stikkelbroeck in
Google Scholar
PubMed Close
,
Philippe A Touraine University Hospitals Pitié Salpêtrière - Charles Foix, Paris, France

Search for other papers by Philippe A Touraine in
Google Scholar
PubMed Close
,
Alex Lewis Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by Alex Lewis in
Google Scholar
PubMed Close
,
John Porter Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by John Porter in
Google Scholar
PubMed Close
,
Helen Coope Neurocrine Biosciences Inc, London, United Kingdom

Search for other papers by Helen Coope in
Google Scholar
PubMed Close
, and
Richard J Ross The University of Sheffield, Sheffield, United Kingdom

Search for other papers by Richard J Ross in
Google Scholar
PubMed Close

). Prednisolone, prednisone, and dexamethasone are also given in the evening with the rationale that, being more potent and with a longer half-life, they could control the overnight rise in ACTH ( 6 ). Prednisolone and prednisone have a longer plasma elimination

Article Type:
Research Article
Collections:
Adrenal
DOI:
https://doi.org/10.1530/EC-24-0150
Volume/Issue:
Volume 13: Issue 8
Open access
Alexander Tacey Institute for Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australia
Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia

Search for other papers by Alexander Tacey in
Google Scholar
PubMed Close
,
Lewan Parker Institute for Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australia
Institute for Physical Activity and Nutrition, Deakin University, Geelong, Victoria, Australia

Search for other papers by Lewan Parker in
Google Scholar
PubMed Close
,
Bu B Yeap Medical School, University of Western Australia, and Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Perth, Western Australia, Australia

Search for other papers by Bu B Yeap in
Google Scholar
PubMed Close
,
John Joseph PathWest Laboratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Search for other papers by John Joseph in
Google Scholar
PubMed Close
,
Ee M Lim PathWest Laboratory Medicine, Sir Charles Gairdner Hospital, Perth, Western Australia, Australia

Search for other papers by Ee M Lim in
Google Scholar
PubMed Close
,
Andrew Garnham Institute for Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australia

Search for other papers by Andrew Garnham in
Google Scholar
PubMed Close
,
David L Hare University of Melbourne and the Department of Cardiology, Austin Health, Melbourne, Victoria, Australia

Search for other papers by David L Hare in
Google Scholar
PubMed Close
,
Tara Brennan-Speranza Department of Physiology and Bosch Institute for Medical Research, University of Sydney, Sydney, New South Wales, Australia

Search for other papers by Tara Brennan-Speranza in
Google Scholar
PubMed Close
, and
Itamar Levinger Institute for Health and Sport (IHES), Victoria University, Melbourne, Victoria, Australia
Department of Medicine-Western Health, Australian Institute for Musculoskeletal Science (AIMSS), Melbourne Medical School, The University of Melbourne, Melbourne, Victoria, Australia

Search for other papers by Itamar Levinger in
Google Scholar
PubMed Close

prednisolone, are used primarily for anti-inflammatory purposes in the treatment of numerous acute and chronic illnesses and diseases ( 3 , 4 , 5 ). As much as 17% of the population are prescribed GC on an annual basis, indicating the substantial prevalence

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0473
Volume/Issue:
Volume 8: Issue 2
Open access
Marcus Quinkler Endocrinology in Charlottenburg, Berlin, Germany

Search for other papers by Marcus Quinkler in
Google Scholar
PubMed Close
,
Bertil Ekman Departments of Endocrinology and Medical and Health Sciences, Linköping University, Linköping, Sweden

Search for other papers by Bertil Ekman in
Google Scholar
PubMed Close
,
Claudio Marelli Shire International GmbH, Zug, Switzerland

Search for other papers by Claudio Marelli in
Google Scholar
PubMed Close
,
Sharif Uddin Shire, Lexington, Massachusetts, USA

Search for other papers by Sharif Uddin in
Google Scholar
PubMed Close
,
Pierre Zelissen Department of Internal Medicine and Endocrinology, University Medical Center Utrecht, Utrecht, the Netherlands

Search for other papers by Pierre Zelissen in
Google Scholar
PubMed Close
,
Robert D Murray Department of Endocrinology, Leeds Teaching Hospitals NHS Trust, St James’s University Hospital, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close
, and
on behalf of the EU-AIR Investigators
Search for other papers by on behalf of the EU-AIR Investigators in
Google Scholar
PubMed Close

Introduction Prednisolone is a synthetic glucocorticoid that has been used over the last few decades as pharmacotherapy in a plethora of diseases due to its potent antiinflammatory and immunosuppressive properties ( 1 ). Prednisolone is

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-16-0081
Volume/Issue:
Volume 6: Issue 1
Open access
Sirazum Choudhury Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Sirazum Choudhury in
Google Scholar
PubMed Close
,
Tricia Tan Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Tricia Tan in
Google Scholar
PubMed Close
,
Katharine Lazarus Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Katharine Lazarus in
Google Scholar
PubMed Close
, and
Karim Meeran Endocrinology and Investigative Medicine, Department of Metabolism, Digestion and Reproduction, Imperial College London, Commonwealth Building, London, UK
Department of Endocrinology, Imperial College Healthcare NHS Trust, London, UK

Search for other papers by Karim Meeran in
Google Scholar
PubMed Close

-term outcomes. Dual-release hydrocortisone (herein referred to as Plenadren), and prednisolone both offer a once-daily solution to glucocorticoid replacement therapy. Apart from the convenience and improved adherence to treatment with once-daily dosing, both

Article Type:
Review Article
DOI:
https://doi.org/10.1530/EC-20-0473
Volume/Issue:
Volume 10: Issue 2
Open access
Kamran Iqbal Shire, London, UK

Search for other papers by Kamran Iqbal in
Google Scholar
PubMed Close
,
Kate Halsby pH Associates, Marlow, UK

Search for other papers by Kate Halsby in
Google Scholar
PubMed Close
,
Robert D Murray Leeds Centre for Diabetes & Endocrinology, St James’s University Hospital, Leeds, UK

Search for other papers by Robert D Murray in
Google Scholar
PubMed Close
,
Paul V Carroll Department of Endocrinology, Guy’s & St. Thomas’ NHS Foundation Trust, London, UK

Search for other papers by Paul V Carroll in
Google Scholar
PubMed Close
, and
Robert Petermann Shire, Vienna, Austria

Search for other papers by Robert Petermann in
Google Scholar
PubMed Close

common in women and in those aged between 30 and 50 years old ( 2 ), although it can present at any age. Patients with AI need to take daily life-long medication. This consists of a glucocorticoid, typically hydrocortisone (HC) or prednisolone, and in

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-18-0418
Volume/Issue:
Volume 8: Issue 1
Open access
Stephanie Burger-Stritt Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany

Search for other papers by Stephanie Burger-Stritt in
Google Scholar
PubMed Close
,
Linda Bachmann Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany

Search for other papers by Linda Bachmann in
Google Scholar
PubMed Close
,
Max Kurlbaum Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany

Search for other papers by Max Kurlbaum in
Google Scholar
PubMed Close
, and
Stefanie Hahner Endocrinology and Diabetes Unit, Department of Medicine I, University Hospital Wuerzburg, Wuerzburg, Germany

Search for other papers by Stefanie Hahner in
Google Scholar
PubMed Close

Study design The trial was conducted as a single-center, open-label, sequence-randomized, cross-over, bioequivalence study. Prednisolone levels after VAG-PN were compared to levels after REC-PN in the same patients over a period of 6 h. Secondary

Article Type:
Research Article
DOI:
https://doi.org/10.1530/EC-19-0024
Volume/Issue:
Volume 8: Issue 4
Open access